Scientists may be able to create new drugs to tackle some viruses
See also:
Related news stories:
Imperial College London News Release
Under strict embargo for
14.00 Eastern Time / 19.00 GMT
Thursday 21 January 2010
New video footage of a virus infecting cells is challenging what researchers have long believed about how viruses spread, suggesting that scientists may be able to create new drugs to tackle some viruses.
Previously, viruses were thought to spread by entering a cell, replicating there, and then being released to infect new cells, so that the rate of spread of a virus would be limited by how quickly it could replicate in each cell.
However, a virus called vaccinia spreads in a different and much faster way, according to a new study in the journal Science by researchers from Imperial College London, funded by the Medical Research Council.
Vaccinia is a poxvirus and is the vaccine that was used to eradicate smallpox. Using live video microscopy, the scientists discovered that it was spreading four times more quickly than thought possible, based on the rate at which it replicates.
Videos of virus-infected cells revealed that the virus spreads by surfing from cell to cell, using a mechanism that allows it to bounce past cells that are already infected and reach uninfected cells as quickly as possible.
Early after vaccinia infects a cell, it expresses two viral proteins on the cell surface, which marks the cell as infected. When further virus particles reach the infected cell, these proteins cause the host cell to push out snake-like projections called "actin tails," which drive the virus particles away towards other cells that they can infect. The particles thus bounce from one cell surface to another until they land on an uninfected cell.
In the study, the researchers prevented the virus from making the proteins needed to make the actin tails in the early stages of infecting a cell and showed that this slowed the spread of the virus dramatically.
The researchers believe that other viruses also employ rapid spreading mechanisms. For instance, herpes simplex virus (HSV-1), which causes cold sores, spreads at a faster rate than should be possible given its replication rate. Thus, this phenomenon discovered with vaccinia may be a common feature a viruses.
The discovery may ultimately enable scientists to create new antiviral drugs that target this spreading mechanism.
Lead study author Professor Geoffrey L. Smith, a Wellcome Trust Principal Research Fellow from the Section of Virology at Imperial College London, said: “The ability of viruses to spread rapidly is often critical for their ability to cause disease. Therefore, understanding how viruses spread is fundamental to designing strategies to block spread and thereby prevent disease.”
“For more than 50 years viruses were thought to spread by an iterative process of infection, replication, release and re-infection, so the rate of spread was limited by the speed of replication. However, my colleagues Virginie Doceul, Mike Hollinshead and Lonnerke van der Linden discovered a novel spreading mechanism that is not limited by virus replication rate and accelerates spread dramatically.
“Shortly after infection vaccinia expresses two virus proteins on the cell surface that mark the cell as infected. This effectively says to additional virus particles trying to infect the cell ’I’m infected already, there is no point coming here, you need to go elsewhere.’ And remarkably the virus particles are physically repelled until they find an uninfected cell. Thus the virus can spread quickly to distant uninfected cells without needing to replicate in each cell on the way.”
“This fundamentally changes how we think about virus dissemination and similar strategies may very well be exploited by many viruses,” added Professor Smith.
-ends-
For further information please contact:
Laura Gallagher
Research Media Relations Manager
Imperial College London
email: l.gallagher@imperial.ac.uk
Tel: +44(0)20 7594 8432
Out of hours duty press officer: +44(0)7803 886 248
Notes to editors:
1. “Repulsion of Superinfecting Virions: A Mechanism for Rapid Virus Spread”
Science, Thursday 21 January 2009
Corresponding author: Professor Geoffrey Smith, Imperial College London (for full list of authors please see paper).
2. About the Medical Research Council
For almost 100 years the Medical Research Council has improved the health of people in the UK and around the world by supporting the highest quality science. The MRC invests in world-class scientists. It has produced 29 Nobel Prize winners and sustains a flourishing environment for internationally recognised research. The MRC focuses on making an impact and provides the financial muscle and scientific expertise behind medical breakthroughs, including one of the first antibiotics penicillin, the structure of DNA and the lethal link between smoking and cancer. Today MRC funded scientists tackle research into the major health challenges of the 21st century. www.mrc.ac.uk
3. About the Wellcome Trust
The Wellcome Trust is the largest charity in the UK. It funds innovative biomedical research, in the UK and internationally, spending over £600 million each year to support the brightest scientists with the best ideas. The Wellcome Trust supports public debate about biomedical research and its impact on health and wellbeing. http://www.wellcome.ac.uk
4. About Imperial College London
Consistently rated amongst the world's best universities, Imperial College London is a science-based i nstitution with a reputation for excellence in teaching and research that attrac ts 14,000 students and 6,000 staff of the highest international quality.
Innovative research at the College explores the interface between science, medicine, engineering and business, delivering practical solutions that improve quality of life and the environment - underpinned by a dynamic enterprise culture.
Since its foundation in 1907, Imperial's contributions to society have included the discovery of penicillin, the development of holography and the foundations of fibre optics. This commitment to the application of research for the benefit of all continues today, with current focuses including interdisciplinary collaborations to improve health in the UK and globally, tackle climate change and develop clean and sustainable sources of energy.
Website: www.imperial.ac.uk
Article text (excluding photos or graphics) available under an Attribution-NonCommercial-ShareAlike Creative Commons license.
Photos and graphics subject to third party copyright used with permission or © Imperial College London.